Trials / Conditions / Ototoxic Hearing Loss
Ototoxic Hearing Loss
5 registered clinical trials studyying Ototoxic Hearing Loss — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Cisplatin-induced Cochlear and Vestibular Damage in Head and Neck Cancer NCT06929468 | Simon Jäger | — |
| Recruiting | Efficacy of Sodium Thiosulfate and Mannitol in Reducing Ototoxicity in Adult Patients Receiving Cisplatin Chem NCT05129748 | Sunnybrook Health Sciences Centre | Phase 2 |
| Recruiting | Ototoxicity in Patients With MoM Hip Bearings NCT06885411 | Reinier Haga Orthopedisch Centrum | — |
| Terminated | Intratympanic Administration of N-acetylcysteine for Protection of Cisplatin-induced Ototoxicity NCT04226456 | Centre Hospitalier Universitaire Saint Pierre | Phase 4 |
| Unknown | Intratympanic N-Acetylcysteine for Prevention of Cisplatin-induced Ototoxicity. NCT04291209 | Sunnybrook Health Sciences Centre | Phase 1 / Phase 2 |